首页> 外文会议>SPIE Conference on Computer-Aided Diagnosis >Radiomics Biomarkers from PET/CT Multi-modality Fusion Images for the Prediction of Immunotherapy Response in Advanced Non-small Cell Lung Cancer Patients
【24h】

Radiomics Biomarkers from PET/CT Multi-modality Fusion Images for the Prediction of Immunotherapy Response in Advanced Non-small Cell Lung Cancer Patients

机译:来自PET / CT多模态融合图像的辐射瘤生物标志物,用于预测晚期非小细胞肺癌患者免疫疗法反应

获取原文

摘要

Purpose: Investigate the ability of using complementary information provided by the fusion of PET/CT images to predict immunotherapy response in non-small cell lung cancer (NSCLC) patients. Materials and methods: We collected 64 patients diagnosed with primary NSCLC treated with anti PD-1 checkpoint blockade. Using PET/CT images, fused images were created following multiple methodologies, resulting in up to 7 different images for the tumor region. Quantitative image features were extracted from the primary image (PET/CT) and the fused images, which included 195 from primary images and 1235 features from the fusion images. Three clinical characteristics were also analyzed. We then used support vector machine (SVM) classification models to identity discriminant features that predict immunotherapy response at baseline. Results: A SVM built with 87 fusion features and 13 primary PET/CT features on validation dataset had an accuracy and area under the ROC curve (AUROC) of 87.5% and 0.82, respectively, compared to a model built with 113 original PET/CT features on validation dataset 78.12% and 0.68. Conclusion: The fusion features shows better ability to predict immunotherapy response prediction compared to individual image features.
机译:目的:研究使用PET / CT图像融合提供的互补信息的能力,以预测非小细胞肺癌(NSCLC)患者的免疫疗法应答。材料和方法:我们收集了64名诊断患有抗PD-1检查点封闭的原发性NSCLC的患者。使用PET / CT图像,在多种方法中创建融合图像,导致肿瘤区域最多7种不同的图像。从主图像(PET / CT)和融合图像中提取定量图像特征,该图像包括从融合图像的初级图像和1235个特征的195。还分析了三种临床特征。然后,我们将支持向量机(SVM)分类模型用于预测基线的免疫疗法响应的身份判别特征。结果:验证数据集中的87个融合功能和13个主要PET / CT功能的SVM分别在ROC曲线(AUROC)下,分别为87.5%和0.82,与带有113原装PET / CT的模型分别为87.5%和0.82验证数据集的功能78.12%和0.68。结论:与个体图像特征相比,融合特征表明了预测免疫疗法响应预测的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号